This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Proteintech Group
product type :
antibody
product name :
Phospho-TDP43 (Ser409/410)
catalog :
22309-1-AP
quantity :
100UL
price :
299 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry
citations: 24
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig 1a
Smethurst P, Newcombe J, Troakes C, Simone R, Chen Y, Patani R, et al. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol Dis. 2016;96:236-247 pubmed publisher
  • western blot; human; fig 3
Alquezar C, Salado I, de la Encarnación A, Perez D, Moreno F, Gil C, et al. Targeting TDP-43 phosphorylation by Casein Kinase-1? inhibitors: a novel strategy for the treatment of frontotemporal dementia. Mol Neurodegener. 2016;11:36 pubmed publisher
Termsarasab P, Thammongkolchai T, Gao J, Wang L, Liang J, Wang X. Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice. Exp Biol Med (Maywood). 2020;:1535370220914253 pubmed publisher
Martínez González L, Rodríguez Cueto C, Cabezudo D, Bartolomé F, Andrés Benito P, Ferrer I, et al. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment. Sci Rep. 2020;10:4449 pubmed publisher
Huang S, Wu L, Lee M, Chang C, Cheng W, Fang Y, et al. A robust TDP-43 knock-in mouse model of ALS. Acta Neuropathol Commun. 2020;8:3 pubmed publisher
Gregory J, Livesey M, McDade K, Selvaraj B, Barton S, Chandran S, et al. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain. J Pathol. 2020;250:67-78 pubmed publisher
Hideshima M, Beck G, Yamadera M, Motoyama Y, Ikenaka K, Kakuda K, et al. A clinicopathological study of ALS with L126S mutation in the SOD1 gene presenting with isolated inferior olivary hypertrophy. Neuropathology. 2019;: pubmed publisher
Sacino A, Prokop S, Walsh M, Adamson J, Subramony S, Krans A, et al. Fragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathology. Acta Neuropathol Commun. 2019;7:158 pubmed publisher
Ng J, Hanspal M, Matharu N, Barros T, Esbjörner E, Wilson M, et al. Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis. Biochemistry. 2019;58:4086-4095 pubmed publisher
Gregory J, McDade K, Bak T, Pal S, Chandran S, Smith C, et al. Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS. J Neurol Neurosurg Psychiatry. 2019;: pubmed publisher
Gregory J, Elliott E, McDade K, Bak T, Pal S, Chandran S, et al. Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2019;: pubmed publisher
Regalado Reyes M, Furcila D, Hernandez F, Avila J, DeFelipe J, León Espinosa G. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression. J Alzheimers Dis. 2019;69:277-288 pubmed publisher
Huntley M, Gao J, Termsarasab P, Wang L, Zeng S, Thammongkolchai T, et al. Association between TDP-43 and mitochondria in inclusion body myositis. Lab Invest. 2019;: pubmed publisher
Chen Y, Cohen T. Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation. J Biol Chem. 2019;294:3696-3706 pubmed publisher
Statland J, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, et al. Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Muscle Nerve. 2019;59:201-207 pubmed publisher
Posa D, Martínez González L, Bartolomé F, Nagaraj S, Porras G, Martinez A, et al. Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients. Mol Neurobiol. 2019;56:2424-2432 pubmed publisher
Cykowski M, Powell S, Appel J, Arumanayagam A, Rivera A, Appel S. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2018;6:28 pubmed publisher
Henstridge C, Sideris D, Carroll E, Rotariu S, Salomonsson S, Tzioras M, et al. Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:213-226 pubmed publisher
Wilhite R, Sage J, Bouzid A, Primavera T, Agbas A. Platelet phosphorylated TDP-43: an exploratory study for a peripheral surrogate biomarker development for Alzheimer's disease. Future Sci OA. 2017;3:FSO238 pubmed publisher
Cykowski M, Powell S, Peterson L, Appel J, Rivera A, Takei H, et al. Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol. 2017;76:402-413 pubmed publisher
Mackenzie I, Neumann M. Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol. 2017;134:79-96 pubmed publisher
King A, Troakes C, Smith B, Nolan M, Curran O, Vance C, et al. ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation. Acta Neuropathol Commun. 2015;3:62 pubmed publisher
Chou C, Alexeeva O, Yamada S, Pribadi A, Zhang Y, Mo B, et al. PABPN1 suppresses TDP-43 toxicity in ALS disease models. Hum Mol Genet. 2015;24:5154-73 pubmed publisher
Okamoto K, Fujita Y, Hoshino E, Tamura Y, Fukuda T, Hasegawa M, et al. An autopsy case of familial amyotrophic lateral sclerosis with a TARDBP Q343R mutation. Neuropathology. 2015;35:462-8 pubmed publisher
product information
CatalogNo :
22309-1-AP
AntigenName :
Phospho-TDP43 (Ser409/410)
Package :
100UL
Price :
299 USD
Exsists20ul :
20ul trial size available
FullName :
TAR DNA binding protein
Immunogen :
Peptide
Species :
human, mouse
Host :
Rabbit
IsConjugated :
Unconjugated
AntigenSpecies :
human
Application :
WB, IHC, IF, ELISA
Clonlity :
Polyclonal
IsoType :
IgG
Synonyms :
phospho TDP43, phospho(409/410)-TDP43, Phospho-TDP43 (Ser409/410), TARDBP, TDP43
PrimaryOrSecondary :
Primary
AntibodyBuffer :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
GenBankNo :
NM_007375
Category :
Binding Proteins;Cytoskeleton/Scaffold Proteins;Metabolism;Neurology;
PurifyMethod :
Antigen affinity purification
NewAb :
False
IsSellable :
True
AppTiter :
WB 1:600 ;
company information
Proteintech Group
2201 W. Campbell Park Dr. STE12
Chicago, IL 60612
Proteintech@ptglab.com
https://www.ptglab.com
1-312-455-8498
headquarters: USA
At Proteintech, we produce every single antibody we sell; we do not rely on or supply to any other antibody providers: our products are unique and we are 100% accountable for each one. We realize this accountability by validating in-house, providing extensive technical support and guaranteeing your success: in addition to helping you troubleshoot your experiment, we will offer you a full cash refund if you are in any way dissatisfied. We can guarantee satisfaction because we have confidence in our products, confidence cultivated by the science behind our antibodies: we make them using as much of the native protein as possible, and purifying them using affinity purification with the original antigen. We carry out antibody production over a 102-day period, which allows for better antigen fitting to MHC molecules and affinity maturation in the host. This approach results in higher affinity antibodies with greater sensitivity, which you can use in any application and in multiple species.
You can only buy Proteintech antibodies directly from Proteintech or via one of its approved distributors — when you receive your antibody and see the Proteintech logo on the vial, know that you hold something that is truly unique.